135 related articles for article (PubMed ID: 33717583)
1. Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 cases.
Zhou Y; Gao Y; Zhang N; Li X; Wang H; Wang S; Liu J; Gao H; Wang H
J Thorac Dis; 2021 Feb; 13(2):1100-1105. PubMed ID: 33717583
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
[TBL] [Abstract][Full Text] [Related]
3. Restoration of Patency to Central Airways Occluded by Malignant Endobronchial Tumors Using Intratumoral Injection of Cisplatin.
Mehta HJ; Begnaud A; Penley AM; Wynne J; Malhotra P; Fernandez-Bussy S; Cope J; Shuster JJ; Jantz MA
Ann Am Thorac Soc; 2015 Sep; 12(9):1345-50. PubMed ID: 26072968
[TBL] [Abstract][Full Text] [Related]
4. Bronchoscopic intratumoral injections of cisplatin and endostar as concomitants of standard chemotherapy to treat malignant central airway obstruction.
Jiang W; Yang X; Wang X; Li Y; Yang X; Wang N; Yin B
Postgrad Med J; 2022 Feb; 98(1156):104-112. PubMed ID: 33070116
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal infusion of recombinant human endostatin improves prognosis in gastric cancer ascites.
Zhan Z; Wang X; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Chen B
Future Oncol; 2022 Mar; 18(10):1259-1271. PubMed ID: 35114805
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI to predict response to vinorelbine-cisplatin alone or with rh-endostatin in patients with non-small cell lung cancer and bone metastases: a randomised, double-blind, placebo-controlled trial.
Zhang R; Wang ZY; Li YH; Lu YH; Wang S; Yu WX; Zhao H
Lancet; 2016 Oct; 388 Suppl 1():S95. PubMed ID: 27968915
[TBL] [Abstract][Full Text] [Related]
7. Real-world outcomes of various regimens of recombinant human endostatin combined with chemotherapy in non-driver gene mutation advanced non-small cell lung cancer.
Wang Z; Zhang H; Zhou C; Long X; Guan R; Yang N; Zhang Y
Cancer Med; 2019 Apr; 8(4):1434-1441. PubMed ID: 30762300
[TBL] [Abstract][Full Text] [Related]
8. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
Chen L; Zhu X; Li D; Cai X
J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of rh-endostatin combined with chemotherapy versus chemotherapy alone for advanced NSCLC: a meta-analysis review].
Cao D; Ge W; Wang H; Zhang L; Zheng Y; Zhang J
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):404-13. PubMed ID: 21569645
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis.
Wang CQ; Huang XR; He M; Zheng XT; Jiang H; Chen Q; Fan TY; Zhan L; Ling J; Feng JH; Xiao X; Chen XF; Xiao Z
Front Oncol; 2021; 11():649999. PubMed ID: 34414103
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of recombinant human endostatin during peri-radiotherapy period in advanced non-small-cell lung cancer.
Zhu J; Chen G; Niu K; Feng Y; Xie L; Qin S; Wang Z; Li J; Lang S; Zhuo W; Chen Z; Sun J
Future Oncol; 2022 Mar; 18(9):1077-1087. PubMed ID: 34986655
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer.
Liu ZJ; Wang J; Wei XY; Chen P; Wang LC; Lin L; Sun BC; Li K
J Cancer Res Clin Oncol; 2012 Jun; 138(6):927-37. PubMed ID: 22331237
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study.
Wang ZQ; Wang DS; Wang FH; Ren C; Tan Q; Li YH
Invest New Drugs; 2021 Apr; 39(2):516-523. PubMed ID: 33070249
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model.
Li N; Zheng D; Wei X; Jin Z; Zhang C; Li K
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1131-44. PubMed ID: 22402599
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of adding rh-endostatin to first-line chemotherapy in patients with advanced non-small-cell lung cancer in China.
Wu B; Chen H; Shen J; Ye M
Clin Ther; 2011 Oct; 33(10):1446-55. PubMed ID: 21992806
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.
Chen J; Yao Q; Li D; Zhang J; Wang T; Yu M; Zhou X; Huan Y; Wang J; Wang L
BMC Cancer; 2013 May; 13():248. PubMed ID: 23693018
[TBL] [Abstract][Full Text] [Related]
17. Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial.
Li SY; Li Q; Guan WJ; Huang J; Yang HP; Wu GM; Jin FG; Hu CP; Chen LA; Xu GL; Liu SZ; Wu CG; Han BH; Xiang Y; Zhao JP; Wang J; Zhou X; Li HP; Zhong NS
Lung Cancer; 2016 Aug; 98():43-50. PubMed ID: 27393505
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer.
Celikoglu F; Celikoglu SI; York AM; Goldberg EP
Lung Cancer; 2006 Feb; 51(2):225-36. PubMed ID: 16359751
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of bronchoscopic intratumoral injection of endostar and cisplatin in lung squamous cell carcinoma patients underwent conventional chemoradiotherapy.
Ji Y; Luan S; Yang X; Yin B; Jin X; Wang H; Jiang W
Open Med (Wars); 2023; 18(1):20230640. PubMed ID: 37025426
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.
Lu S; Li L; Luo Y; Zhang L; Wu G; Chen Z; Huang C; Guo S; Zhang Y; Song X; Yu Y; Zhou C; Li W; Liao M; Li B; Xu L; Chen P; Hu C; Hu C
J Thorac Oncol; 2015 Jan; 10(1):206-11. PubMed ID: 25654728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
